Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of prostaglandin receptor antagonists. It plays a critical role in the production of ophthalmic drugs aimed at reducing intraocular pressure in glaucoma patients. Its structural features allow for strong binding affinity and selectivity toward specific prostaglandin receptors, enhancing drug efficacy. Additionally, it is employed in research settings to develop new anti-inflammatory and ocular hypotensive compounds.